Subscribe to Supplier

Home / Videos / Annex 1 and strategies for high-potency therapies

Annex 1 and strategies for high-potency therapies

videosDec Group

August 27th 2025

Episode 7 of Dec Group’s interview series is now live.

In this episode, Managing Director Frederic Dietrich explores Annex 1 and strategies for high-potency therapies, focusing on the challenges of aseptic processing.

He shares how Dec Group’s True End-to-End approach supports customers in navigating the complexities of maintaining aseptic conditions throughout the entire production process — all the way to primary packaging.

CORPORATE VIDEO

True End-to-End Solutions

Dec Group Videos

Dec Group

Contact Information

Address: Z. I. Larges Pièces A, Chemin du Dévent, P. O. Box 9, 1024 Ecublens, Switzerland

Telephone No: +41 21 694 20 40

Email Address: [email protected]

Web Address: http://www.dec-group.net

Facebook

Twitter

Full Supplier Profile Subscribe To Supplier

Contact Dec Group

Simply fill out the form below to contact Dec Group now.

Send Dec Group a Message

View Articles by Dec Group

Annex 1 and strategies for high-potency therapies